HIKAL.NS
Hikal Ltd
Price:  
214.06 
INR
Volume:  
445,393.00
India | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HIKAL.NS EV/EBITDA

19.8%
Upside

As of 2026-05-26, the EV/EBITDA ratio of Hikal Ltd (HIKAL.NS) is 13.96. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HIKAL.NS's latest enterprise value is 33,033.60 mil INR. HIKAL.NS's TTM EBITDA according to its financial statements is 2,366.00 mil INR. Dividing these 2 quantities gives us the above HIKAL.NS EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 14.0x - 16.2x 15.1x
Forward P/E multiples 8.3x - 9.0x 8.7x
Fair Price 214.03 - 289.83 256.40
Upside -0.0% - 35.4% 19.8%
214.06 INR
Stock Price
256.40 INR
Fair Price

HIKAL.NS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-05-22 13.51
2026-05-21 13.50
2026-05-20 13.42
2026-05-19 13.35
2026-05-18 13.08
2026-05-15 13.41
2026-05-14 13.70
2026-05-13 13.28
2026-05-12 13.22
2026-05-11 13.75
2026-05-08 13.79
2026-05-07 13.91
2026-05-06 13.80
2026-05-05 13.03
2026-05-04 13.05
2026-04-30 12.61
2026-04-29 12.67
2026-04-28 12.56
2026-04-27 12.70
2026-04-24 12.29
2026-04-23 12.56
2026-04-22 12.67
2026-04-21 12.55
2026-04-20 12.56
2026-04-17 12.81
2026-04-16 12.68
2026-04-15 12.60
2026-04-13 12.29
2026-04-10 12.16
2026-04-09 11.93
2026-04-08 11.92
2026-04-07 11.39
2026-04-06 11.31
2026-04-02 11.15
2026-04-01 11.14
2026-03-30 10.43
2026-03-27 10.96
2026-03-25 11.41
2026-03-24 11.20
2026-03-23 10.92
2026-03-20 11.59
2026-03-19 11.48
2026-03-18 11.85
2026-03-17 11.67
2026-03-16 11.57
2026-03-13 11.82
2026-03-12 12.22
2026-03-11 12.19
2026-03-10 12.28
2026-03-09 11.89